NCT00383149 2016-03-10A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic CancerR-PharmPhase 2 Completed58 enrolled 13 charts
NCT00016965 2013-06-24BMS-247550 in Treating Patients With Advanced Pancreatic CancerNational Cancer Institute (NCI)Phase 2 Completed